Learn more

ANYUAN BIOTECHNOLOGY SHANGHAI CO LTD

Overview
  • Total Patents
    11
  • GoodIP Patent Rank
    183,053
  • Filing trend
    ⇩ 50.0%
About

ANYUAN BIOTECHNOLOGY SHANGHAI CO LTD has a total of 11 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2012. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are AMPSOURCE BIOPHARMA INC, AVIDBIOTICS CORP and TAYU HUAXIA BIOTECH MEDICAL GROUP CO LTD.

Patent filings in countries

World map showing ANYUAN BIOTECHNOLOGY SHANGHAI CO LTDs patent filings in countries
# Country Total Patents
#1 China 11

Patent filings per year

Chart showing ANYUAN BIOTECHNOLOGY SHANGHAI CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Li Qiang 11
#2 Sun Naichao 10
#3 Zhou Ruoyun 7
#4 Sun Jianyu 5
#5 Gao Yongjuan 5
#6 Li Yuanli 4
#7 Wu Cui 3
#8 Zheng Yuncheng 3
#9 Dong Zhao 2
#10 Wang Zhu 2

Latest patents

Publication Filing date Title
CN110028587A For adjusting the Synergistic type bifunctional protein of blood glucose and lipid
CN109988240A Anti- GPC-3 antibody and application thereof
CN109929035A Anti-human NGF antibody and its preparation method and application
CN107759697A The method for preparing fusion protein
CN104530234A Human VEGF detection combination reagent, reagent box and use method thereof
CN104558175A Reorganized chimeric antibody for resisting VEGF for people and preparation method and use of reorganized chimeric antibody
CN104177496A Hinge region modification body of human IgG2 antibody
CN103397009A Improved-type human coagulation factor FVII-Fc fusion protein as well as preparation method and application thereof
CN103623396A Pharmaceutical composition containing recombinant tissue plasminogen activator
CN104628868A Recombined dimerized antithrombin III-Fc fusion protein and efficient mammalian expression system thereof
CN102690354A Recombined dimerization antithrombin III-Fc fusion protein and mammalian cell efficient expression system thereof